Papers associated with ptger1

???displayGene.coCitedPapers???

???pagination.result.count???

???pagination.result.page??? 1

Sort Newest To Oldest

Sort Oldest To Newest

	Putative metal finger structure of the human immunodeficiency virus type 1 enhancer binding protein HIV-EP1., Maekawa T, Sakura H, Sudo T, Ishii S., J Biol Chem. September 5, 1989; 264 (25): 14591-3.
	Alternating zinc-finger motifs in the human male-associated protein ZFY., Weiss MA, Mason KA, Dahl CE, Keutmann HT., Biochemistry. June 19, 1990; 29 (24): 5660-4.
	Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype., Funk CD, Furci L, FitzGerald GA, Grygorczyk R, Rochette C, Bayne MA, Abramovitz M, Adam M, Metters KM., J Biol Chem. December 15, 1993; 268 (35): 26767-72.
	Cloning, functional expression, and characterization of the human prostaglandin E2 receptor EP2 subtype., Bastien L, Sawyer N, Grygorczyk R, Metters KM, Adam M., J Biol Chem. April 22, 1994; 269 (16): 11873-7.
	GIPC gene family (Review)., Katoh M., Int J Mol Med. June 1, 2002; 9 (6): 585-9.
	Investigating the role of protein folding and assembly in cell-type dependent expression of alpha7 nicotinic receptors using a green fluorescent protein chimera., Lee HK, Gwalani L, Mishra V, Anandjiwala P, Sala F, Sala S, Ballesta JJ, O'Malley D, Criado M, Loring RH., Dev Biol. March 9, 2009; 1259 7-16.
	Atypical antipsychotics as noncompetitive inhibitors of alpha4beta2 and alpha7 neuronal nicotinic receptors., Grinevich VP, Papke RL, Lippiello PM, Bencherif M., Neuropharmacology. August 1, 2009; 57 (2): 183-91.
	α7β2 nicotinic acetylcholine receptors assemble, function, and are activated primarily via their α7-α7 interfaces., Murray TA, Bertrand D, Papke RL, George AA, Pantoja R, Srinivasan R, Liu Q, Wu J, Whiteaker P, Lester HA, Lukas RJ., Mol Pharmacol. February 1, 2012; 81 (2): 175-88.
	The unique α4+/-α4 agonist binding site in (α4)3(β2)2 subtype nicotinic acetylcholine receptors permits differential agonist desensitization pharmacology versus the (α4)2(β2)3 subtype., Eaton JB, Lucero LM, Stratton H, Chang Y, Cooper JF, Lindstrom JM, Lukas RJ, Whiteaker P., J Pharmacol Exp Ther. January 1, 2014; 348 (1): 46-58.
	The prostaglandin EP1 receptor potentiates kainate receptor activation via a protein kinase C pathway and exacerbates status epilepticus., Rojas A, Gueorguieva P, Lelutiu N, Quan Y, Shaw R, Dingledine R., Neurobiol Dis. October 1, 2014; 70 74-89.
	Thujone inhibits the function of α7-nicotinic acetylcholine receptors and impairs nicotine-induced memory enhancement in one-trial passive avoidance paradigm., Sultan A, Yang KS, Isaev D, Nebrisi EE, Syed N, Khan N, Howarth CF, Sadek B, Oz M., Toxicology. June 1, 2017; 384 23-32.

???pagination.result.page??? 1